亚洲分子靶向治疗发展展望
——  作者:    时间:2008-08-01     阅读数: 1317

简介:The success of sorafenib has spurred investigations into exploration of MTTs for HCC.The high incidence, as well as the geographic difference in clinical practice and etiology of HCC, mandate translational research works of MTTs in Asia.

请登录后查看详细内容

发表评论

全部评论